World's first medical networking and resource portal

News & Highlights
Please make use of the search function to browse preferred content
Medical News & Updates
Mar 05
High-salt diet may boost immune response: Study
High-salt diet is bad for health, say numerous studies, but a significant research now reveals that dietary salt could have a biological advantage -- defending the body against invading bacteria.

They found that a high-salt diet increased sodium accumulation in the skin of mice, thereby boosting their immune response to a skin-infecting parasite.

The findings suggest that dietary salt could have therapeutic potential to promote host defence against microbial infections.

Till now, high-salt is clearly known to be detrimental for cardiovascular diseases and stroke.

"Our study challenges this one-sided view and suggests that increasing salt accumulation at the site of infections might be an ancient strategy to ward off infections, long before antibiotics were invented," explained first study author Jonathan Jantsch, microbiologist at Universitatsklinikum Regensburg and Universitat Regensburg in Germany.

A clue to this mystery came when the team noticed an unusually high amount of sodium in the infected skin of mice that had been bitten by cage mates.

Intrigued by this observation, they examined the link between infection and salt accumulation in the skin.

The team found that infected areas in patients with bacterial skin infections also showed remarkably high salt accumulation.

Moreover, experiments in mice showed that a high-salt diet boosted the activity of immune cells called macrophages, thereby promoting the healing of feet that were infected with a protozoan parasite.

The researchers, however, urge caution over the potential health benefits of a high-salt diet.

"Due to the overwhelming clinical studies demonstrating that high dietary salt is detrimental to hypertension and cardiovascular diseases, we feel that at present our data does not justify recommendations on high dietary salt in the general population," Jantsch commented.

"Nevertheless, in situations where endogenous accumulation of salt to sites of infection is insufficient, supplementation of salt might be a therapeutic option," he emphasised.

Moving forward, the researchers will examine how salt accumulates in the skin and triggers immune responses and why salt accumulates in the skin of ageing adults.

"We also think that local application of high-salt-containing wound dressings and the development of other salt-boosting antimicrobial therapies might bear therapeutic potential," the authors concluded.

The paper appeared in the journal Cell Press.

Mar 04
Daily moderate coffee consumption may prevent clogged arteries: Study
A new study has suggested that drinking a few cups of coffee a day may help prevent clogged arteries that could result in heart attacks.

The study was carried out by an international team of researchers led by the Kangbuk Samsung Hospital, Seoul, in the Republic of Korea.

The researchers studied a group of more than 25,000 Korean male and female with an average age of 41 years, who had no signs of heart disease and underwent a routine health checks.

In order to assess the heart health of the participants, researchers used medical scans.

For the study, researchers categorised their coffee consumption as none, less than one cup a day, one to three cups a day, three to five cups per day and five or more per day.

They found the prevalence of detectable CAC was 13.4% amongst the whole group of people and the average consumption of coffee was 1.8 cups per day.

The researchers found people who drank a moderate amount of coffee, three to five cups a day, were less likely to develop early signs of heart disease.

The calcium ratios were 0.77 for people who had less than one cup per day, 0.66 for those having one to three cups every day, 0.59 for those consuming three to five cups per day, and 0.81 for people having at least five cups or more every day compared with non-coffee drinkers.

The research has been published online in the journal Heart.

Mar 02
Eating fatty foods may cut heart attack damage in short run only
It is well known that in the long run, eating fatty foods is bad for you and can increase your risk of having a stroke or heart attack, but as per a new study, a high-fat diet may actually be beneficial to your health and help to reduce heart attack damage.

WKeith Jones of Loyola University Chicago Stritch School of Medicine said that the study improves the understanding of the relationship between diet and health, adding learning about how fat, in the short run, protects against heart attacks could help in the development of better therapies

The study, which is not a license to eat a lot of cheeseburgers and ice cream, may provide new insight into the "obesity paradox": Obesity is a major risk factor for heart disease, but once a heart attack or heart failure does occur, moderately obese patients tend to live longer.

In the study, mice were given a high-fat diet (60 percent of calories from animal fat) before experiencing heart attacks. Mice that consumed a high-fat diet for either one day, one week or two weeks before the heart attack experienced about half as much heart damage as mice that ate a control diet. The benefit was greatest among mice that ate a high-fat diet for one week before the heart attack.

But in mice that ate a high-fat diet for six weeks, the protective effect disappeared. Further research is needed to understand why this is so; the reason may be due to the bad effects of a persistent high-fat diet, said Jones.

Proteins damaged by the heart attack are removed from heart cells as if they were garbage, thus increasing the chances the cells will survive. Acutely, a high-fat diet increases levels of a molecule in the blood that activates protective pathways in heart muscle. This increases the readiness of the "garbage trucks," which means that the cell becomes resistant to damage when the heart attack occurs as a result, more heart muscle survives.

First author Lauren Haar added that the study opens a new perspective on the acute effects of a high-fat diet and future work will determine whether these effects are linked to the obesity paradox and whether studying the mechanism can identify therapeutic targets for cardioprotection.

The study appears in the American Journal of Physiology - Heart and Circulatory Physiology.

Feb 28
Eating fish can make you less aggressive
A new study has revealed that Omega-3 fatty acids and vitamin D may control the brain serotonin.

In a new Children's Hospital Oakland Research Institute (CHORI) study, serotonin is explained as the possible missing link tying together why vitamin D and marine omega-3 fatty acids might ameliorate the symptoms associated with a broad array of brain disorders.

Here they discuss the relevance of these micronutrients for neuropsychiatric illness. Serotonin affects a wide-range of cognitive functions and behaviors including mood, decision-making, social behavior, impulsive behavior, and even plays a role in social decision-making by keeping in check aggressive social responses or impulsive behavior.

Many clinical disorders, such as autism spectrum disorder (ASD), attention deficit hyperactivity disorder (ADHD), bipolar disorder, schizophrenia, and depression share as a unifying attribute low brain serotonin.

Rhonda Patrick said that they explained how serotonin is a critical modulator of executive function, impulse control, sensory gating, and pro-social behavior and linked serotonin production and function to vitamin D and omega-3 fatty acids, suggesting one way these important micronutrients help the brain function and affect the way people behave.

Eicosapentaenoic acid (EPA) increases serotonin release from presynaptic neurons by reducing inflammatory signaling molecules in the brain known as E2 series prostaglandins, which inhibit serotonin release and suggests how inflammation may negatively impact serotonin in the brain.

Their paper illuminates the mechanistic links that explain why low vitamin D and marine omega-3 deficiencies interacts with genetic pathways, such as the serotonin pathway, that are important for brain development, social cognition, and decision-making, and how these gene-micronutrient interactions may influence neuropsychiatric outcomes.

Bruce Ames added that vitamin D, which is converted to a steroid hormone that controls about 1,000 genes, many in the brain, is a major deficiency in the US and omega-3 fatty acid deficiencies are very common because people don't eat enough fish.

The study is published in FASEB Journal.

Feb 27
Vitamin D deficiency causes diabetes, not obesity
A new study has examined that people who have low levels of vitamin D are more likely to have diabetes, regardless of how much they weigh.

The study conducted by the Endocrine Society found that people who have low levels of vitamin D are more likely to be obese and they also are more likely to have Type 2 diabetes, prediabetes and metabolic syndrome than people with normal vitamin D levels.

Vitamin D helps the body absorb calcium and maintain bone and muscle health. The skin naturally produces this vitamin after exposure to sunlight. People also absorb smaller amounts of the vitamin through foods, such as milk fortified with vitamin D. More than 1 billion people worldwide are estimated to have deficient levels of vitamin D due to limited sunshine exposure.

Feb 26
Black tea substance may treat bone loss
Japanese researchers have found that a substance in black tea may be effective for treating osteoporosis, a disease that causes bones to become weak and brittle.

The team, including Keizo Nishikawa, assistant professor at Osaka University, found that theaflavin-3, or TF-3, a substance in black tea, blocks an enzyme - DNA methyltransferase - that increases osteoclasts, cells that destroy bone tissues.

In a study published in the journal Nature Medicine, researchers said that after TF-3 was administered to mice suffering from osteoporosis, their bone volume recovered to levels similar to those of normal mice.

If the experimental conditions are applied to humans, however, a person weighing 60 kg would need to drink 60 cups of black tea every three days, 'The Japan Times' reported.

The discovery may pave the way for development of teas or supplement foods containing a large amount of TF-3.

However, Nishikawa said that products using TF-3 may have very bitter taste because it is a type of catechin, a bittering agent.

Feb 25
How breakfasts and dinners can help control diabetes
A new study has claimed that a high energy breakfast combined with a low energy dinner helps control blood sugar better than in type 2 diabetics, than a low energy breakfast and a high energy dinner.

The small study included 18 individuals (8 men, 10 women), with type 2 diabetes of less than 10 years duration, an age range 30-70 years, body mass index (BMI) 22-35 kg/m2, and treated with metformin and/or dietary advice (eight patients with diet alone and 10 with diet and metformin).

The results showed that post-meal glucose levels were 20 percent lower and levels of insulin, C-peptide and GLP-1 were 20 percent higher in participants on the B diet compared with the D diet. Despite the diets containing the same total energy and same calories during lunch, lunch in the B diet resulted in lower blood glucose (by 21-25 percent) and higher insulin (by 23 percent) compared with the lunch in the D diet.

Prof. Oren Froy, one of the authors of the study from Hebrew University of Jerusalem, said that the observations suggest that a change in meal timing influences the overall daily rhythm of post-meal insulin and incretin and results in a substantial reduction in the daily post-meal glucose levels. It may be a crucial factor in the improvement of glucose balance and prevention of complications in type 2 diabetes and lend further support to the role of the circadian system in metabolic regulation.

Prof. Daniela Jakubowicz Jakubowicz concluded that high energy intake at breakfast is associated with significant reduction in overall post-meal glucose levels in diabetic patients over the entire day. The dietary adjustment may have a therapeutic advantage for the achievement of optimal metabolic control and may have the potential for being preventive for cardiovascular and other complications of type 2 diabetes.

The study is published in Diabetologia.

Feb 24
New drug effective for hormone-resistant breast cancer
A new drug that works by blocking molecules responsible for cancer cell growth has been found to be effective for advanced breast cancer patients.

The drug called palbociclib, an investigational oral medication, has been found to be well tolerated and extends progression-free survival (PFS) in newly diagnosed cancer.

The palbociclib was recently approved by the US Food and Drug Administration (FDA) for metastatic breast cancer patients just beginning to undergo endocrine therapy.

"The FDA approval has expanded treatments options for many metastatic breast cancer patients, but these new results are showing how effective the drug can also be for breast cancer patients who have already tried endocrine therapies and may be running out of options," said Angela DeMichele from Perelman School of Medicine at University of Pennsylvania.

The drug was developed by researchers at Penn Medicine.

Patients enrolled in the trial had previously undergone several prior chemotherapy and hormonal regimen for metastatic disease.

"The drug was extremely well-tolerated in this trial, and the absence of symptoms commonly associated with cancer treatment, such as nausea, diarrhoea, or pain was remarkable," said professor Peter O'Dwyer at Perelman School of Medicine at University of Pennsylvania.

"The palbociclib drug may be effective in other types of cancer that operate by a similar mechanism. These trials are currently ongoing," said Amy Clark, from Perelman School of Medicine at University of Pennsylvania.

The results appeared in Clinical Cancer Research.

Feb 23
Soft drink consumers at a higher risk of cancer
People who consume one or more cans of cold drinks per day are exposing themselves to a potential carcinogen, warns a new study.

The ingredient, 4-methylimidazole (4-MEI) - a possible human carcinogen - is formed during the manufacture of some kinds of caramel colour. Caramel colour is a common ingredient in colas and other dark soft drinks.

"Soft drink consumers are being exposed to an avoidable and unnecessary cancer risk from an ingredient that is being added to these beverages simply for aesthetic purposes," said Keeve Nachman, senior author of the study.

Building on an analysis of 4-MEI concentrations in 11 different soft drinks first published by Consumer Reports in 2014, researchers estimated exposure to 4-MEI from caramel-coloured soft drinks and modelled the potential cancer burden related to routine soft drink consumption levels in the United States.

"This unnecessary exposure poses a threat to public health and raises questions about the continued use of caramel colouring in soda," Nachman of Johns Hopkins Center for a Liveable Future (CLF).

Results indicated that levels of 4-MEI could vary substantially across samples, even for the same type of beverage.

While there is currently no federal limit for 4-MEI in food or beverages, Consumer Reports petitioned the Food and Drug Administration last year to set limits for the potential carcinogen.

"This new analysis underscores our belief that people consume significant amounts of soda that unnecessarily elevate their risk of cancer over the course of a lifetime," said Urvashi Rangan, executive director for Consumer Reports' Food Safety and Sustainability Center.

The results were published online in the journal PLOS One.

Feb 21
Drug-resistant malaria parasite from Myanmar threatens India
India faces the imminent threat of malaria parasites that are resistant to the drug artemisinin, the frontline treatment against malaria, spreading from Myanmar into its territory, putting thousands of lives at risk, researchers have warned.

The research team confirmed resistant parasites in Homalin, Sagaing Region located only 25 kms from the Indian border.

If drug resistance spreads from Asia to the African sub-continent, or emerges in Africa independently, millions of lives will be at risk, the researchers added.

"We are facing the imminent threat of resistance spreading into India, with thousands of lives at risk," explained professor Mike Turner, head of infection & immunobiology at Britain-based Wellcome Trust.

The researchers examined whether parasite samples collected at 55 malaria treatment centres across Myanmar carried mutations in specific regions of the parasite's kelch gene (K13) - a known genetic marker of artemisinin drug resistance.

The team obtained the DNA sequences of 940 samples of malaria infections (known as Plasmodium falciparum malaria parasites) from across Myanmar and neighbouring border regions in Thailand and Bangladesh between 2013 and 2014. Of those 940 samples, 371 (39 percent) carried a resistance-conferring K13 mutation.

Using this information, the researchers developed maps to display the predicted extent of artemisinin resistance determined by the prevalence of K13 mutations.

The maps suggest that the overall prevalence of K13 mutations was greater than ten percent in large areas of the East and North of Myanmar, including areas close to the border with India.

The collection of samples from across Myanmar and its border regions was led by Kyaw Myo Tun of Defence Services Medical Research Centre, Napyitaw, Myanmar and coordinated by the Mahidol-Oxford Tropical Medicine Research Unit (MORU) in Bangkok, Thailand.

"Drug resistant malaria parasites in the 1960s originated in Southeast Asia and from there spread through Myanmar to India, and then to the rest of the world where it killed millions of people," Turner noted.

"The new research shows that history is repeating itself with parasites resistant to artemisinin drugs, the mainstay of modern malaria treatment, now widespread in Myanmar," Turner explained.

The study appeared online in the journal Lancet Infectious Diseases.

Browse Archive